The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bristol-Myers Squibb; Jazz Pharmaceuticals; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Jazz Pharmaceuticals; Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - Amgen; Jazz Pharmaceuticals
Treatment-free remission (TFR) following frontline (1L) nilotinib (NIL) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): 192-week data from the ENESTfreedom study.
 
Francis J. Giles
Employment - Actuate Therapeutics
Leadership - Epigene Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics
 
Tamas Masszi
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Pfizer; Takeda
 
María Teresa Gómez Casares
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Incyte; Janssen; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Incyte; Janssen; Novartis; Pfizer
 
Andrzej Hellmann
Travel, Accommodations, Expenses - Novartis
 
Jesper Stentoft
Research Funding - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
 
Eibhlin Conneally
Honoraria - Jazz Pharmaceuticals; Novartis; Pfizer
Consulting or Advisory Role - Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Pfizer
 
Valentin García Gutierrez
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
 
Norbert Gattermann
Honoraria - Novartis
Consulting or Advisory Role - Novartis; Silence Therapeutics
Research Funding - Alexion Pharmaceuticals; Takeda
Travel, Accommodations, Expenses - Novartis
 
Phillipp D. Le Coutre
No Relationships to Disclose
 
Bruno Martino
No Relationships to Disclose
 
Susanne Saussele
Honoraria - Bristol-Myers Squibb; Incyte; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; Incyte; Novartis
Travel, Accommodations, Expenses - Novartis
 
Jerald P. Radich
No Relationships to Disclose
 
David M. Ross
Honoraria - Bristol-Myers Squibb; Celgene; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Research Funding - Abbvie (Inst); ASLAN Pharmaceuticals (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Imago Pharma (Inst); NOHLA Therapeutics (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
 
Giuseppe Saglio
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Novartis; Pfizer
 
Manu Sondhi
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Suddhasatta Acharyya
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Paola Aimone
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Andreas Hochhaus
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis